Edition:
United States

ICU Medical Inc (ICUI.OQ)

ICUI.OQ on NASDAQ Stock Exchange Global Select Market

135.00USD
2:44pm EST
Change (% chg)

$0.50 (+0.37%)
Prev Close
$134.50
Open
$134.55
Day's High
$135.95
Day's Low
$134.10
Volume
36,058
Avg. Vol
57,797
52-wk High
$154.25
52-wk Low
$85.72

ICUI.OQ

Chart for ICUI.OQ

About

ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure... (more)

Overall

Beta: 0.32
Market Cap(Mil.): $2,196.43
Shares Outstanding(Mil.): 16.33
Dividend: --
Yield (%): --

Financials

  ICUI.OQ Industry Sector
P/E (TTM): 38.87 33.73 30.76
EPS (TTM): 3.46 -- --
ROI: 9.61 13.22 14.89
ROE: 9.71 16.84 16.30

Pfizer to sell infusion business to ICU Medical, take stake

Pfizer Inc said on Thursday it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company.

Oct 06 2016

UPDATE 4-Pfizer to sell infusion business to ICU Medical, take stake

Oct 6 Pfizer Inc said on Thursday it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company.

Oct 06 2016

ICU Medical to buy Pfizer's infusion therapy business for $1 bln

Oct 6 Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock.

Oct 06 2016

BRIEF-ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock

* ICU Medical Inc to acquire the Hospira Infusion Systems business from Pfizer Inc for $1 billion in cash and stock

Oct 06 2016

BRIEF-ICU Medical sees 2016 adj earnings per share $4.45-$4.60

* Q2 earnings per share view $1.05 -- Thomson Reuters I/B/E/S

Aug 08 2016

Earnings vs. Estimates